This article is more than 5 years old. Information may no longer be current.

Seven updates in thyroid cancer treatment

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The American Thyroid Association designated January as Thyroid Awareness Month. This event attempts to bring educational resources and funding for thyroid-related diseases and thyroid cancer to patients, physicians and researchers.

HemOnc Today has compiled a list of seven updates in thyroid cancer treatment and outcomes.

The use of lenvatinib (Lenvima, Eisai) for the treatment of radioiodine-refractory differentiated thyroid cancer among adults appeared relatively effective, but adverse events are common and should be monitored. READ MORE.

Lobectomy appeared to be a safe and reliable first-line treatment for patients with contralateral nonsuspicious thyroid nodules and small, low-risk papillary thyroid carcinoma. READ MORE.

Adults diagnosed with thyroid cancer have increased risks for circulatory conditions, diabetes, disorders of lipid metabolism, eye disorders and heart disease compared with adults never diagnosed with thyroid cancer. READ MORE.

Long-term survivors of pediatric differentiated thyroid cancer are more likely to have diastolic dysfunction, suggesting early cardiac aging, than controls who were never exposed to differentiated thyroid cancer. READ MORE.

Findings from a large international genetic database provided new insight on genetic mutations known to cause thyroid cancer. READ MORE.

The overall incidence of thyroid cancer is “leveling off” in the United States, but rising among young, black and Hispanic populations. READ MORE.

Adults with low-risk differentiated thyroid cancer may be at lower risk for disease-related mortality than those with intermediate- and high-risk cancer, suggesting less aggressive treatments may be appropriate. READ MORE.